PAR paradigm biopharmaceuticals limited..

4.48%

32.0¢

Ann: Loyalty and Piggyback Options Program, page-494

First 494 Last

Share
Profile

Follow
Mozzarc

4,871 Posts.

7554

21/02/25

11:24

Post #: 77962734
Share

Originally posted by bedger: ↑

Oooh, too tempting. I just let someone have a few of my options at $0.21 - couldn't resist. Someone's getting a bit excited on a partnership....the stock is looking a little thin on the offer understandably.

Do consider people, that options are a double edged sword. Yes if we get a deal and the stock above $0.65 they will be in the money and we in glee, but also the company makes a nice lot of capital off them on new share issue. There will be some 97,000,000 new shares on market (presently 390 million). A lot of investors will have forked out X times $0.65 to buy the stock. Some shareholders may have to sell a proportion of X stock on market to pay back the funds needed....

The company is as much the winner from options as the shareholders it extolled the benefits to, make no mistake - if the share price north of $0.65 on expiry. Ultimately it all results in shareholders giving the company more money via a raise, be it options initially issued or shares. Options just sound so much more inviting when marketed by companies as bonuses to shareholders, as PAR have. Their exercise admittedly predicated on some successful achievements by the company reflected in the share price.

Expand

I do like this better than a SPP.

A SPP so far is usually negative, we buy in at x only to see the SP fall to x and oftentimes BELOW x.

At LEAST with options WE are the ones that determine WHEN to exercise, or when to ACT.

Plus the bonus golden Piggies are a material extension of time, time to be possibly right at not much more than a strike of 65 cents...ie $1.00

PAR Price at posting: 58.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 494 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 32.0¢		Change -0.015(4.48%)		Mkt cap ! $124.6M

Open	High	Low	Value	Volume
33.5¢	34.0¢	31.5¢	$215.7K	663.5K

Buyers (Bids)

No.	Vol.	Price($)
3	30081	31.5¢

Sellers (Offers)

Price($)	Vol.	No.
32.5¢	10905	1

View Market Depth

No.	Vol.	Price($)
1	8058	0.315
1	16129	0.310
1	50000	0.305
2	52500	0.300
3	117880	0.295

Price($)	Vol.	No.
0.325	10905	1
0.330	10	1
0.335	3500	1
0.340	113110	3
0.350	53621	7

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PAR (ASX) Chart

Ann: Loyalty and Piggyback Options Program, page-494

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Loyalty and Piggyback Options Program, page-494

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News